rs797044802
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002180.3(IGHMBP2):c.449+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_002180.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive distal spinal muscular atrophy 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease axonal type 2SInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary peripheral neuropathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IGHMBP2 | NM_002180.3 | c.449+1G>A | splice_donor_variant, intron_variant | Intron 3 of 14 | ENST00000255078.8 | NP_002171.2 | ||
| IGHMBP2 | XM_047426881.1 | c.449+1G>A | splice_donor_variant, intron_variant | Intron 3 of 14 | XP_047282837.1 | |||
| IGHMBP2 | XM_017017671.3 | c.449+1G>A | splice_donor_variant, intron_variant | Intron 3 of 11 | XP_016873160.1 | |||
| IGHMBP2 | XM_005273976.3 | c.449+1G>A | splice_donor_variant, intron_variant | Intron 3 of 8 | XP_005274033.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
IGHMBP2-related disorder Pathogenic:1
The IGHMBP2 c.449+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in the compound heterozygous state with an aberrant splicing IGHMBP2 deep intronic variant in an infant with spinal muscular atrophy with respiratory distress type 1 (SMARD1, Bodle et al. 2021. PubMed ID: 33189025). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice donor site in IGHMBP2 are expected to be pathogenic. Additionally, a different nucleotide change impacting the same GT donor site (c.449+1G>T) has been reported in the homozygous state in an infant with SMARD1 (Stalpers et al. 2013. PubMed ID: 23566544). This variant is interpreted as likely pathogenic. -
Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 534927). Disruption of this splice site has been observed in individuals with Charcot-Marie-Tooth disease (PMID: 25568292, 27450922). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 3 of the IGHMBP2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in IGHMBP2 are known to be pathogenic (PMID: 14681881, 25439726, 25568292). -
Charcot-Marie-Tooth disease axonal type 2S Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at